title: Effects of L-DOPA on spatiotemporal contrast sensitivity in Parkinson's disease.
authors.affiliation: URA CNRS 1166, Marseille, France.
authors.forename: D R
authors.initials: DR
authors.lastname: Mestre
authors.forename: O
authors.initials: O
authors.lastname: Blin
authors.forename: C L
authors.initials: CL
authors.lastname: van den Brand
authors.forename: J P
authors.initials: JP
authors.lastname: Azulay
authors.forename: G
authors.initials: G
authors.lastname: Serratrice
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000978:Antiparkinson Agents / Q000627:therapeutic use*; D015350:Contrast Sensitivity / Q000187:drug effects*; D018450:Disease Progression; D005260:Female; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009068:Movement / Q000502:physiology; D010300:Parkinson Disease / Q000188:drug therapy* / Q000523:psychology*; D013028:Space Perception / Q000187:drug effects; D013998:Time Perception / Q000187:drug effects
chemical_list: D000978:Antiparkinson Agents; D007980:Levodopa